These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28991025)

  • 21. Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South Africa.
    McGrath N; Lessells RJ; Newell ML
    HIV Med; 2015 Sep; 16(8):512-8. PubMed ID: 25959724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy.
    Freedberg KA; Kumarasamy N; Losina E; Cecelia AJ; Scott CA; Divi N; Flanigan TP; Lu Z; Weinstein MC; Wang B; Ganesh AK; Bender MA; Mayer KH; Walensky RP
    AIDS; 2007 Jul; 21 Suppl 4(Suppl 4):S117-28. PubMed ID: 17620747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort study.
    Scott CA; Iyer HS; McCoy K; Moyo C; Long L; Larson BA; Rosen S
    BMC Public Health; 2014 Mar; 14():296. PubMed ID: 24684772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of first-line antiretroviral therapy and correlates of longitudinal changes in CD4 and viral load among HIV-infected children in Ghana.
    Barry O; Powell J; Renner L; Bonney EY; Prin M; Ampofo W; Kusah J; Goka B; Sagoe KW; Shabanova V; Paintsil E
    BMC Infect Dis; 2013 Oct; 13():476. PubMed ID: 24119088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating strategies to improve HIV care outcomes in Kenya: a modelling study.
    Olney JJ; Braitstein P; Eaton JW; Sang E; Nyambura M; Kimaiyo S; McRobie E; Hogan JW; Hallett TB
    Lancet HIV; 2016 Dec; 3(12):e592-e600. PubMed ID: 27771231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa.
    Bor J; Fox MP; Rosen S; Venkataramani A; Tanser F; Pillay D; Bärnighausen T
    PLoS Med; 2017 Nov; 14(11):e1002463. PubMed ID: 29182641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunologic and virological response to ART among HIV infected individuals at a tertiary hospital in Ghana.
    Obiri-Yeboah D; Pappoe F; Baidoo I; Arthur F; Hayfron-Benjamin A; Essien-Baidoo S; Kwakye-Nuako G; Ayisi Addo S
    BMC Infect Dis; 2018 May; 18(1):230. PubMed ID: 29783953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
    Lodi S; Phillips A; Logan R; Olson A; Costagliola D; Abgrall S; van Sighem A; Reiss P; Miró JM; Ferrer E; Justice A; Gandhi N; Bucher HC; Furrer H; Moreno S; Monge S; Touloumi G; Pantazis N; Sterne J; Young JG; Meyer L; Seng R; Dabis F; Vandehende MA; Pérez-Hoyos S; Jarrín I; Jose S; Sabin C; Hernán MA;
    Lancet HIV; 2015 Aug; 2(8):e335-43. PubMed ID: 26423376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis.
    Mugglin C; Estill J; Wandeler G; Bender N; Egger M; Gsponer T; Keiser O;
    Trop Med Int Health; 2012 Dec; 17(12):1509-20. PubMed ID: 22994151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017.
    Ngongo NM; Darcis G; Nanituna HS; Mambimbi MM; Maes N; Mashi ML; Bepouka Izizag B; Moutschen M; Lepira Bompeka F
    PLoS One; 2021; 16(11):e0259073. PubMed ID: 34739506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Updated direct costs of medical care for HIV-infected patients within a regional population from 2006 to 2017.
    Krentz HB; Vu Q; Gill MJ
    HIV Med; 2020 May; 21(5):289-298. PubMed ID: 31852032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Costs of HIV/AIDS treatment in Indonesia by time of treatment and stage of disease.
    Siregar AY; Tromp N; Komarudin D; Wisaksana R; van Crevel R; van der Ven A; Baltussen R
    BMC Health Serv Res; 2015 Sep; 15():440. PubMed ID: 26424195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attrition when providing antiretroviral treatment at CD4 counts >500cells/μL at three government clinics included in the HPTN 071 (PopART) trial in South Africa.
    Bock P; Fatti G; Ford N; Jennings K; Kruger J; Gunst C; Louis F; Grobbelaar N; Shanaube K; Floyd S; Grimwood A; Hayes R; Ayles H; Fidler S; Beyers N;
    PLoS One; 2018; 13(4):e0195127. PubMed ID: 29672542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost and resource use of patients on antiretroviral therapy in the urban and semiurban public sectors of South Africa.
    Meyer-Rath G; Miners A; Santos AC; Variava E; Venter WD
    J Acquir Immune Defic Syndr; 2012 Nov; 61(3):e25-32. PubMed ID: 22895437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.
    Brown JP; Ngwira B; Tafatatha T; Crampin AC; French N; Koole O
    AIDS Res Ther; 2016; 13():24. PubMed ID: 27398087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cost-effectiveness of prophylaxis strategies for individuals with advanced HIV starting treatment in Africa.
    Walker SM; Cox E; Revill P; Musiime V; Bwakura-Dangarembizi M; Mallewa J; Cheruiyot P; Maitland K; Ford N; Gibb DM; Walker AS; Soares M;
    J Int AIDS Soc; 2020 Mar; 23(3):e25469. PubMed ID: 32219991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Who is utilizing anti-retroviral therapy in Ghana: an analysis of ART service utilization.
    Dako-Gyeke P; Snow R; Yawson AE
    Int J Equity Health; 2012 Oct; 11():62. PubMed ID: 23072340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of management strategies and clinical status on costs of care for advanced HIV.
    Barnett PG; Chow A; Joyce VR; Bayoumi AM; Griffin SC; Sun H; Holodniy M; Brown ST; Cameron W; Sculpher M; Youle M; Anis AH; Owens DK
    Am J Manag Care; 2014 May; 20(5):e129-37. PubMed ID: 25326927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A stepped-wedge randomised trial on the impact of early ART initiation on HIV-patients' economic outcomes in Eswatini.
    Steinert JI; Khan S; Mlambo K; Walsh FJ; Mafara E; Lejeune C; Wong C; Hettema A; Ogbuoji O; Vollmer S; De Neve JW; Mazibuko S; Okello V; Bärnighausen T; Geldsetzer P
    Elife; 2020 Aug; 9():. PubMed ID: 32831169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of antiretroviral therapy expansion strategies in Vietnam.
    Tran DA; Wilson DP; Shakeshaft A; Ngo AD; Reyes J; Doran C; Zhang L
    AIDS Patient Care STDS; 2014 Jul; 28(7):365-71. PubMed ID: 24983389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.